within Pharmacolibrary.Drugs.V_Various.V03A_AllOtherTherapeuticProducts.V03AB33_Hydroxocobalamin;

model Hydroxocobalamin
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 5.055555555555556e-07,
    adminDuration = 600,
    adminMass = 5000 / 1000000,
    adminCount = 1,
    Vd = 0.0024100000000000002,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.00093,
    k12 = 8.944444444444445e-07,
    k21 = 8.944444444444445e-07);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Hydroxocobalamin</td></tr><tr><td>ATC code:</td><td>V03AB33</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>5000</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>2.41</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.026</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Hydroxocobalamin is a form of vitamin B12, used as a therapeutic agent mainly in the treatment of vitamin B12 deficiency, pernicious anemia, and as an antidote for cyanide poisoning. It is approved by health authorities for these uses and is administered parenterally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are from studies in healthy adult volunteers, single-dose intravenous administration.</p><h4>References</h4><ol><li><p>Uhl, W, et al., &amp; Kovar, A (2008). Changes in blood pressure after administration of hydroxocobalamin: relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers. <i>Clinical toxicology (Philadelphia, Pa.)</i> 46(6) 551–577. DOI:<a href=\"https://doi.org/10.1080/15563650701829763\">10.1080/15563650701829763</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18584369/\">https://pubmed.ncbi.nlm.nih.gov/18584369</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.V.V03AB33 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Hydroxocobalamin;
